Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Predicts 5-Year Amputation in Patients With Peripheral Artery Disease
- 1 June 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 35 (6) , 1532-1537
Abstract
Objective—: Patients with peripheral artery disease are at risk for critical limb ischemia and amputation. Accumulation of advanced glycation end products is increased and predictive for coronary and cerebrovascular events in several high cardiovascular risk groups. We hypothesized that accumulation of tissue advanced glycation end products, measured by skin autofluorescence (SAF), predicts amputation in patients with peripheral artery disease. Approach and Results—: Between October 2007 and June 2008, 252 patients with peripheral artery disease were included at the outpatient clinic. During a 5-year follow-up, 22 (9%) had an amputation because of critical limb ischemia. Competing risks regression analysis showed a subproportional hazard ratio of 3.05 (95% confidence interval [CI], 1.87–4.96); P P =0.004. In patients with Fontaine stage I and II only (n=215), SAF was the only predictor for amputation, subproportional hazard ratio 4.05 (95% CI, 2.09–7.83); P P =0.003. Conclusions—: Skin autofluorescence, as a measure of tissue advanced glycation end products deposition, predicts amputation in patients with peripheral artery disease during a 5-year follow-up, independent from the presence of diabetes mellitus and Fontaine stage. Even at lower Fontaine stage (I or II), SAF is a strong predictor of amputation. The multiplication of Fontaine stage by SAF results in a good prediction model of amputation.Keywords
This publication has 18 references indexed in Scilit:
- Skin Autofluorescence Is Associated With 5-Year Mortality and Cardiovascular Events in Patients With Peripheral Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophilsAtherosclerosis, 2013
- High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery diseaseAmerican Heart Journal, 2013
- Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemiaJournal of Vascular Surgery, 2010
- Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 DiabetesDiabetes Care, 2006
- Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial diseaseEuropean Heart Journal, 2006
- Advanced Glycation End ProductsCirculation, 2006
- Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal DiseaseAnnals of the New York Academy of Sciences, 2005
- Simple non-invasive assessment of advanced glycation endproduct accumulationDiabetologia, 2004